Neurosurgery
Medical specialty of disorders which affect any portion of the nervous system.
Follow Neurosurgery on Notably News to receive short updates to your email — rarely!
We include updates on Intracranial aneurysm, Kyon Ki, Laminectomy, Cerebral angiography, Subarachnoid hemorrhage, Howard Dully, Dura mater, Idiopathic intracranial hypertension, Neurofibromatosis type II, Vasospasm, Thalavattam, Brain transplant, Discectomy, Parietal bone, Psychosurgery, Carotid endarterectomy ... and more.
2024 |
Neutron capture therapy of cancer
University of Tsukuba's iBNCT system first used clinically for active clinical trials.
|
2023 |
Neutron capture therapy of cancer
Cancer Intelligence Care Systems' 7Li(p,n)7Be system deployed at Edogawa Hospital in Tokyo for active clinical trials.
|
2022 |
Neutron capture therapy of cancer
Neuboron Medical Group began clinical trials at Xiamen Humanity Hospital in China, and Dawon Medax began clinical trials at BNCT Clinic in Incheon, South Korea.
|
2022 |
Neutron capture therapy of cancer
Dawon Medax's 9Be(p,n)9B system first used clinically at BNCT Clinic in Songdo, South Korea for clinical trials.
|
2022 |
Neutron capture therapy of cancer
Neuboron Medical Group's NeuPex system first used clinically at Xiamen Humanity Hospital in China for clinical trials.
|
2022 |
Neutron capture therapy of cancer
Anticipated start of clinical studies in Finland using an accelerator neutron source designed and fabricated by Neutron Therapeutics from the United States.
|
2021 |
Neutron capture therapy of cancer
A new BNCT treatment facility with an accelerator designed by Neutron Therapeutics was prepared for clinical studies after completing dosimetric studies.
|
2021 |
Neutron capture therapy of cancer
Miyatake and co-workers conducted a clinical study treating 44 patients with recurrent high-grade meningiomas using Boron Neutron Capture Therapy (BNCT) at the Kyoto University Research Reactor Institute in Kumatori, Japan. The study involved intravenous administration of boronophenylalanine two hours before neutron irradiation.
|
2020 |
Neutron capture therapy of cancer
NeuCure system deployed at Kansai BNCT Research Center, Osaka Medical and Pharmaceutical University for active clinical use and received approval.
|
2019 |
Neutron capture therapy of cancer
Cancer Intelligence Care Systems' 7Li(p,n)7Be system first used clinically at National Cancer Center in Tokyo for clinical trials.
|
2018 |
Neutron capture therapy of cancer
A comprehensive review of boron delivery agents for neutron capture therapy of cancer was published by Barth, R.F., Mi, P., and Yang, W. in Cancer Communications, providing an updated assessment of research progress.
|
2016 |
Neutron capture therapy of cancer
NeuCure system deployed at Southern Tohoku General Hospital for active clinical use and received approval.
|
2014 |
Neutron capture therapy of cancer
Up to this point, neutron sources for Neutron Capture Therapy (NCT) were exclusively limited to nuclear reactors.
|
2014 | Conclusion of the NSQIP analysis of common neurosurgical procedures, which identified key surgical interventions including anterior cervical discectomy and fusion (ACDF), craniotomy for brain tumor (CBT), discectomy, laminectomy, and posterolateral lumbar fusion (PLF). |
2012 |
Neutron capture therapy of cancer
Sumitomo Heavy Industries' NeuCure system first used clinically at Particle Radiation Oncology Research Center, Kyoto University.
|
2011 |
Neutron capture therapy of cancer
Fukushima nuclear disaster provided significant impetus for developing accelerator-based neutron sources for clinical use.
|
This contents of the box above is based on material from the Wikipedia articles Neurosurgery & Neutron capture therapy of cancer, which are released under the Creative Commons Attribution-ShareAlike 4.0 International License.